These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2845845)

  • 21. Quantitating presentation of MHC class I-restricted antigens.
    Chen W; Bennink JR; Yewdell JW
    Methods Mol Biol; 2001; 156():245-54. PubMed ID: 11068765
    [No Abstract]   [Full Text] [Related]  

  • 22. Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.
    Tamminen WL; Wraith D; Barber BH
    Eur J Immunol; 1987 Jul; 17(7):999-1006. PubMed ID: 3497045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes.
    Gotch F; McMichael A; Smith G; Moss B
    J Exp Med; 1987 Feb; 165(2):408-16. PubMed ID: 3029268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR
    Science; 1989 Jun; 244(4908):1072-5. PubMed ID: 2471266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Major histocompatibility complex I of swine respiratory cells presents conserved regions of influenza proteins.
    Lamont EA; Poulin E; Sreevatsan S; Cheeran MC
    J Gen Virol; 2018 Mar; 99(3):303-308. PubMed ID: 29458525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formaldehyde inactivation of measles virus abolishes CD46-dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells.
    Cardoso AI; Beauverger P; Gerlier D; Wild TF; Rabourdin-Combe C
    Virology; 1995 Sep; 212(1):255-8. PubMed ID: 7676641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.
    Voeten JT; Bestebroer TM; Nieuwkoop NJ; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2000 Aug; 74(15):6800-7. PubMed ID: 10888619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.
    Price GE; Ou R; Jiang H; Huang L; Moskophidis D
    J Exp Med; 2000 Jun; 191(11):1853-67. PubMed ID: 10839802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM; Turner RV; Biddison WE; Coligan JE
    J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition by major histocompatibility complex class I-restricted cytolytic T lymphocytes of cells expressing vaccinia-encoded viral and class I proteins.
    Andrew ME; Coupar BE; Boyle DB; Blanden RV
    Eur J Immunol; 1987 Oct; 17(10):1515-8. PubMed ID: 3500060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein.
    Bodmer HC; Pemberton RM; Rothbard JB; Askonas BA
    Cell; 1988 Jan; 52(2):253-8. PubMed ID: 2449284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and in vivo distribution of influenza-virus-specific T-lymphocytes in the murine respiratory tract.
    McDermott MR; Lukacher AE; Braciale VL; Braciale TJ; Bienenstock J
    Am Rev Respir Dis; 1987 Jan; 135(1):245-9. PubMed ID: 2432811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes.
    Esquivel F; Yewdell J; Bennink J
    J Exp Med; 1992 Jan; 175(1):163-8. PubMed ID: 1309852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection.
    Wiley JA; Hogan RJ; Woodland DL; Harmsen AG
    J Immunol; 2001 Sep; 167(6):3293-9. PubMed ID: 11544317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986.
    Townsend AR; Rothbard J; Gotch FM; Bahadur G; Wraith D; McMichael AJ
    J Immunol; 2006 May; 176(9):5141-50. PubMed ID: 16621977
    [No Abstract]   [Full Text] [Related]  

  • 36. Persistence of cell-mediated immunity to influenza A virus in mice.
    Ashman RB
    Immunology; 1982 Sep; 47(1):165-8. PubMed ID: 6214498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell mediated immunity in virus infection.
    Askonas BA; Taylor PM
    Immunol Lett; 1987 Dec; 16(3-4):337-40. PubMed ID: 2832319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A one-size-fits-all flu vaccine?
    Kaiser J
    Science; 2006 Apr; 312(5772):380-2. PubMed ID: 16627732
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of class I- and II-restricted T cell recognition of the identical peptide.
    Perkins DL; Berriz G; Wang YS; Smith JA; Gefter ML
    Eur J Immunol; 1991 Nov; 21(11):2781-9. PubMed ID: 1718759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
    J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.